SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 83 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2014. The put-call ratio across all filers is 2.83 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $112,000 | -38.5% | 64,476 | -21.1% | 0.11% | -32.1% |
Q2 2015 | $182,000 | +65.5% | 81,694 | +44.5% | 0.16% | +54.2% |
Q1 2015 | $110,000 | -49.5% | 56,518 | -31.4% | 0.11% | -49.0% |
Q4 2014 | $218,000 | -14.2% | 82,383 | -2.6% | 0.21% | -26.6% |
Q3 2014 | $254,000 | -37.3% | 84,606 | -14.6% | 0.29% | -35.1% |
Q2 2014 | $405,000 | -11.2% | 99,023 | -3.9% | 0.44% | -5.8% |
Q1 2014 | $456,000 | -8.8% | 103,021 | +8.0% | 0.47% | -14.3% |
Q4 2013 | $500,000 | – | 95,361 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 37,069,140 | $64,500,000 | 87.00% |
ARMISTICE CAPITAL, LLC | 2,000,000 | $3,480,000 | 1.19% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 432,259 | $752,000 | 0.28% |
Geller Advisors LLC | 187,323 | $326,000 | 0.21% |
CAXTON CORP | 57,000 | $99,000 | 0.13% |
Verity Asset Management, Inc. | 64,476 | $112,000 | 0.11% |
TFS CAPITAL LLC | 367,364 | $639,000 | 0.06% |
Cutler Capital Management, LLC | 72,500 | $126,000 | 0.06% |
LUCAS CAPITAL MANAGEMENT | 21,100 | $37,000 | 0.02% |
Nine Chapters Capital Management LLC | 129,700 | $226,000 | 0.02% |